Research never stops

Hit identification

Evotec is able to offer screening services for biochemical, functional and/or cellular responses using its proprietary high-throughput screening technology and/or other commercial platforms. This can be through providing access to its own 400,000 compound screening library together with an exclusive access to the Sanofi library of 700,000 molecules or using the client's library of compounds.

Evotec’s technology platform includes nuclear magnetic resonance spectrometry, surface plasmon resonance spectrometry, high-content screening, high-throughput mass-spectrometry based screening and a comprehensive structure-based drug design platform.

Furthermore, Evotec has twenty years of experience in assay development, covering the major target classes, but also new target classes in the field of epigenetics, transporter biology and protein-protein interaction.

Hit identification

High-throughput screening

- read more

High-content screening

- read more

Structure-based drug design

- read more

EVOmab

- read more